Skin Barrier Damage and Itch: Review of Mechanisms, Topical Management and Future Directions

被引:117
作者
Yosipovitch, Gil [1 ,2 ]
Misery, Laurent [3 ,4 ]
Proksch, Ehrhardt [5 ]
Metz, Martin [6 ]
Staender, Sonja [7 ]
Schmelz, Martin [8 ]
机构
[1] Univ Miami, Dr Phillip Frost Dept Dermatol, Miami, FL USA
[2] Univ Miami, Itch Ctr, Miami, FL USA
[3] Univ West Brittany, Dept Dermatol, Brest, France
[4] Univ West Brittany, French Expert Ctr Itch, Brest, France
[5] Univ Kiel, Dept Dermatol, Kiel, Germany
[6] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
[7] Univ Munster, Ctr Chron Pruritus, Dept Dermatol, Munster, Germany
[8] Heidelberg Univ, Dept Expt Pain Res, Mannheim, Germany
关键词
pruritus; dry skin; skin barrier; emollients; ATOPIC-DERMATITIS; CHRONIC PRURITUS; DRY-SKIN; ADULT PATIENTS; DOUBLE-BLIND; EFFICACY; ECZEMA; PATHOGENESIS; EMOLLIENTS; STRONTIUM;
D O I
10.2340/00015555-3296
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Barrier damage, dry skin and itch are intricately linked and form the basis of many common skin diseases. Damage from environmental insults, or genetic or inflammatory causes, can impair the skin barrier, resulting in an increase in transepidermal water loss and activation of itch-associated nerve fibres. The itch-scratch cycle can perpetuate skin barrier damage and itch. Topical therapeutic strategies are utilised to overcome dry skin and itch, primarily in the form of emollients. Recent advances in our understanding of the mechanisms underlying itch have enabled the development of new topical therapies, which may be incorporated into existing treatment regimes. Ultimately, treatment of dry skin and itch must be highly tailored to the individual according to their needs.
引用
收藏
页码:1201 / 1209
页数:9
相关论文
共 122 条
[1]   Skin Barrier Defects in Atopic Dermatitis [J].
Agrawal, Rachana ;
Woodfolk, Judith A. .
CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (05)
[2]   Transepidermal water loss in healthy adults: a systematic review and meta-analysis update [J].
Akdeniz, M. ;
Gabriel, S. ;
Lichterfeld-Kottner, A. ;
Blume-Peytavi, U. ;
Kottner, J. .
BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (05) :1049-1055
[3]   Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis [J].
Akiyama, Masashi .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 88 (01) :3-9
[4]   Skin pH: From Basic Science to Basic Skin Care [J].
Ali, Saba M. ;
Yosipovitch, Gil .
ACTA DERMATO-VENEREOLOGICA, 2013, 93 (03) :261-267
[5]   Skin Barrier Integrity and Natural Moisturising Factor Levels After Cumulative Dermal Exposure to Alkaline Agents in Atopic Dermatitis [J].
Angelova-Fischer, Irena ;
Dapic, Irena ;
Hoek, Anne-Karin ;
Jakasa, Ivone ;
Fischer, Tobias W. ;
Zillikens, Detlef ;
Kezic, Sanja .
ACTA DERMATO-VENEREOLOGICA, 2014, 94 (06) :640-644
[6]  
Baeumer Wolfgang, 2007, Inflammation & Allergy Drug Targets, V6, P17, DOI 10.2174/187152807780077318
[7]   PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models [J].
Barr, Travis P. ;
Garzia, Chris ;
Guha, Srijoy ;
Fletcher, Elizabeth K. ;
Nga Nguyen ;
Wieschhaus, Adam J. ;
Ferrer, Lluis ;
Covic, Lidija ;
Kuliopulos, Athan .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (02) :412-421
[8]   Chronic pruritus - more than a symptom: a qualitative investigation into patients' subjective illness perceptions [J].
Bathe, Anja ;
Weisshaar, Elke ;
Matterne, Uwe .
JOURNAL OF ADVANCED NURSING, 2013, 69 (02) :316-326
[9]   The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities [J].
Biro, Tamas ;
Toth, Balazs I. ;
Hasko, Gyoergy ;
Paus, Ralf ;
Pacher, Pal .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (08) :411-420
[10]   Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial [J].
Bissonnette, R. ;
Poulin, Y. ;
Zhou, Y. ;
Tan, J. ;
Hong, H. C. ;
Webster, J. ;
Ip, W. ;
Tang, L. ;
Lyle, M. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) :853-860